#US; #FDA; #BloodPlasma; #Covid19Treatment;
Washington, Aug 24 (Canadian-Media): Emergency authorisation for the use of plasma to treat coronavirus patients was given Aug 23 by the United States (US) Food and Drug Administration (FDA), media reports said.
U.S. FDA. Image credit: Twitter handle
This procedure has already been used on over 70,000 people in the US and uses antibody-rich blood plasma from people who've recovered from the disease.
US President Donald Trump said the blood plasma treatment could reduce deaths by nearly 35 percent.
Describing the procedure as a powerful therapy, Trump appealed Americans to come forward to donate plasma if they've recovered from COVID-19.
Early research suggests, said the FDA that besides decreasing mortality, blood plasma can improve patient health if administered within the first three days of their hospitalisation.
The agency said it came to the conclusion about the safety of this treatment after an extensive review of data collected during recent months.